NYSE: RCUS       Arcus Biosciences Inc
Last Price Today's Change   Day's Range   Trading Volume
38.41   +1.77 (4.83%)  36.50 - 39.01  388,600


Avg Volume (4 weeks):558,705
4 Weeks Range:25.55 - 40.01
4 Weeks Price Volatility (%):
52 Weeks Range:8.55 - 40.01
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company which focuses on creating innovative cancer immunotherapies by leveraging underexploited biological opportunities. The company focuses on an ATP-adenosine pathway which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. The pipeline products of the company include dual and selective A2R antagonists, small-molecule and antibody programs which target solid tumors. The company operates through the single segment being the business of developing and commercializing immunotherapies.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

6239  2800  512  101 

Top 10 Active Counters
 AMC 3.51+0.60 
 CTRM 0.405-0.008 
 ADMP 1.79-0.54 
 GME 65.01+22.42 
 SNDL 0.645+0.003 
 AZRX 1.84+0.62 
 PLTR 32.58+6.73 
 SENS 2.31+0.08 
 MKD 1.53+0.64 
 NIO 61.95+3.00